PubRank
Search
About
G M McKhann
Author PubWeight™ 89.03
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
Brain
1995
2.61
2
Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Neurology
2007
2.32
3
Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery.
Arch Neurol
2001
2.30
4
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.
Neurology
1997
2.15
5
Cellular autofluorescence--is it due to flavins?
J Histochem Cytochem
1979
1.99
6
Pathology of the motor-sensory axonal Guillain-Barré syndrome.
Ann Neurol
1996
1.85
7
Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?
Arch Neurol
2001
1.83
8
The clinical correlates of high-titer IgG anti-GM1 antibodies.
Ann Neurol
1994
1.79
9
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma.
Ann Neurol
1996
1.59
10
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.
J Neurocytol
1996
1.51
11
Resolution of central pain after embolization of an arteriovenous malformation. Case report.
J Neurosurg
1999
1.51
12
Physiologic-pathologic correlation in Guillain-Barré syndrome in children.
Neurology
2000
1.43
13
Functional specialization and topographic segregation of hippocampal astrocytes.
J Neurosci
1998
1.42
14
Statin use and neurologic morbidity after coronary artery bypass grafting: A cohort study.
Neurology
2009
1.41
15
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
J Infect Dis
2001
1.40
16
Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency.
Science
1971
1.35
17
Serum antibodies to gangliosides in Guillain-Barré syndrome.
Ann Neurol
1988
1.34
18
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.
Ann Neurol
1996
1.34
19
Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man.
J Neuropathol Exp Neurol
1973
1.32
20
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
Ann Neurol
1999
1.28
21
Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
N Engl J Med
1976
1.21
22
The in vivo and in vitro synthesis of sulphatides during development.
J Neurochem
1967
1.15
23
The pathophysiology of oral pharyngeal apraxia and mutism following posterior fossa tumor resection in children.
J Neurosurg
1995
1.15
24
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.
Neurology
1998
1.14
25
Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid.
Neurology
1977
1.13
26
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.
Ann Neurol
1988
1.13
27
Neurobehavioural sequelae of cardiopulmonary bypass.
Lancet
1999
1.11
28
Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome.
J Infect Dis
1997
1.09
29
Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
J Infect Dis
2001
1.07
30
Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up.
J Neurol Neurosurg Psychiatry
2004
1.05
31
Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange.
Ann Neurol
1979
1.03
32
A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid.
Ann Neurol
1980
1.03
33
Neuropsychologic change after cardiac surgery: a critical review.
J Cardiothorac Vasc Anesth
1996
1.02
34
Intensive management and treatment of severe Guillain-Barré syndrome.
Crit Care Med
1993
1.01
35
Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
J Infect Dis
1999
0.99
36
Patterns of recovery in the Guillain-Barre syndromes.
Neurology
1997
0.99
37
Neurologic injury in cardiac surgical patients with a history of stroke.
Ann Thorac Surg
1996
0.96
38
Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem.
Ann Thorac Surg
1999
0.95
39
The effect of malnutrition on the synthesis of a myelin lipid.
Pediatrics
1967
0.95
40
A radioimmunoassay for myelin basic protein and its use for quantitative measurements.
J Neurochem
1975
0.95
41
Additional electron microscopic observations on two cases of Batten-Spielmeyer-Vogt disease. (Neuronal ceroid-lipofuscinosis).
Acta Neuropathol
1971
0.93
42
Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease.
J Neurol Neurosurg Psychiatry
2006
0.93
43
Human autoimmune neuropathies.
Annu Rev Neurosci
1998
0.93
44
Transfection of neonatal rat Schwann cells with SV-40 large T antigen gene under control of the metallothionein promoter.
J Cell Biol
1987
0.91
45
Myelinogenesis in optic nerve. A morphological, autoradiographic, and biochemical analysis.
J Cell Biol
1977
0.91
46
Machado-Joseph disease in a Sicilian-American family.
J Neurogenet
1986
0.90
47
Characterization of cerebroside sulfotransferase from rat brain.
J Biol Chem
1971
0.89
48
Gangliosides in neurological diseases.
BMJ
1993
0.88
49
Studies of water soluble lipoproteins in rat brain.
J Neurochem
1968
0.88
50
Myelin subfractions in developing rat brain: characterization and sulphatide metabolism.
J Neurochem
1973
0.87
51
Metachromatic leukodystrophy: clinical and enzymatic parameters.
Neuropediatrics
1984
0.87
52
Temporal lobe stimulation reveals anatomic distinction between auditory naming processes.
Neurology
2003
0.86
53
Orbital assault with a pencil: evaluating vascular injury.
AJR Am J Roentgenol
1999
0.86
54
Campylobacter serology in patients with Chinese paralytic syndrome.
Lancet
1991
0.86
55
Student test scores are improved in a virtual learning environment.
Adv Physiol Educ
2000
0.85
56
Characterization of sulphatide-containing lipoproteins in rat brain.
J Neurochem
1968
0.85
57
Coronary-artery bypass surgery and the brain.
N Engl J Med
2001
0.85
58
Multiple sclerosis.
Annu Rev Neurosci
1982
0.84
59
Guillain-Barré syndrome: is there a role for plasmapheresis?
Neurology
1980
0.83
60
(2- 3 H)glycerol as a precursor of phospholipids in rat brain: evidence for lack of recycling.
J Neurochem
1973
0.83
61
Metabolism of sulfatides. I. The effect of galactocerebrosides on the synthesis of sulfatides.
Biochem Biophys Res Commun
1965
0.83
62
Molecular mimicry in Guillain-Barré syndrome.
Ann N Y Acad Sci
1998
0.82
63
Metabolic properties of maintained oligodendroglia purified from brain.
J Biol Chem
1978
0.82
64
The isolation of neurons from normal and abnormal human cerebral cortex.
Arch Neurol
1969
0.81
65
Galactocerebroside sulfotransferase: further characterization of the enzyme from rat brain.
J Neurochem
1978
0.81
66
Light-scattering patterns of isolated oligodendroglia.
J Histochem Cytochem
1974
0.81
67
Incorporation of radioactive sulphate into sulphatide during myelination in cultures of rat cerebellum.
J Neurochem
1972
0.80
68
Globoid cell (Krabbe's) leukodystrophy: heterozygote detection in cultured skin fibroblasts.
Am J Hum Genet
1973
0.80
69
Radioactive measurement of 2' ,3'-cyclic nucleotide 3'-phosphodiesterase activity in the central and peripheral nervous system and in extraneural tissue.
Anal Biochem
1978
0.80
70
Selective growth of rat Schwann cells in neuron- and serum-free primary culture.
J Neurosci
1987
0.80
71
The dynamics of a lipidosis. Turnover of sulfatide, steroid sulfate, and polysaccharide sulfate in metachromatic leukodystrophy.
Arch Neurol
1967
0.80
72
A cellular approach to neurological disease.
Johns Hopkins Med J
1978
0.79
73
Synthesis of sulphatide-containing lipoproteins in rat brain.
J Neurochem
1969
0.79
74
Antiserums to neurons and to oligodendroglia from mammalian brain.
Science
1977
0.79
75
Changing views of Guillain-Barré syndrome.
Ann Neurol
1997
0.78
76
Flow cytometry of isolated cells from the brain.
Anal Quant Cytol
1980
0.78
77
Cell therapy for Parkinson's disease.
N Engl J Med
2001
0.78
78
Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue.
J Neuropathol Exp Neurol
1977
0.78
79
Maintenance of neurons isolated in bulk from rat brain: incorporation of radiolabeled substrates.
Brain Res
1977
0.78
80
Granulomatous angiitis of the central nervous system with aneurysms on multiple cerebral arteries.
Trans Am Neurol Assoc
1973
0.77
81
Properties and metabolism of soluble lipoproteins containing choline and ethanolamine phospholipids in rat brain.
J Neurochem
1973
0.77
82
Activity of 2',3'-cyclic-nucleotide 3'-phosphodiesterase in regions of rat brain during development: quantitative relationship to myelin basic protein.
J Neurochem
1978
0.76
83
Adverse cerebral outcomes after coronary bypass surgery.
N Engl J Med
1997
0.75
84
The effect of inhibitors of protein synthesis on the formation of myelin.
Trans Am Neurol Assoc
1970
0.75
85
The effects of cell isolation techniques on neuronal membrane receptors.
Brain Res
1975
0.75
86
The future of child neurology.
J Child Neurol
1991
0.75
87
Isolation of cells from normal and abnormal brain.
Trans Am Neurol Assoc
1977
0.75
88
Activity of 2',3'-cyclic-nucleotide 3'-phosphodiesterase in cerebrospinal fluid of patients with demyelinating disorders.
Neurosci Lett
1978
0.75
89
Recommendations of the International Roundtable Workshop on Bovine Spongiform Encephalopathy.
J Am Vet Med Assoc
1992
0.75
90
The effects of inhibitors of protein synthesis on incorporation of lipids into myelin.
J Neurochem
1971
0.75
91
[Neuronal damage in the hippocampus of inbred mouse strains in the models of epilepsy induced by kainic acid and pilocarpine].
Morfologiia
2004
0.75
92
The reaction of myelin phospholipids with phospholipase C and D.
Arch Biochem Biophys
1975
0.75
93
Synthesis of cerebrosides by intact oligodendroglia maintained in culture.
Neurosci Lett
1977
0.75
94
Drugs and poisons in mental retardation.
Science
1967
0.75
95
Speaking of Dr. Ford for the field of neurology (Frank R. Ford).
Johns Hopkins Med J
1971
0.75
96
Measurement of myelin basic protein in cerebrospinal fluid.
Ann Neurol
1989
0.75
97
Isolated myelin quantitatively adsorbs antibody to basic protein.
Brain Res
1974
0.75
98
Neurobiology: mind and matter.
Am J Dis Child
1969
0.75
99
Nutrition and brain development.
Res Publ Assoc Res Nerv Ment Dis
1973
0.75
100
Maintenance of bulk isolated neurons.
Neurosci Lett
1976
0.75
101
Biochemical approaches to the nosology of nervous system defects, I.
Birth Defects Orig Artic Ser
1971
0.75
102
Sulfate metabolism in metachromatic leukodystrophy.
Trans Am Neurol Assoc
1964
0.75
103
Evaluation of the metabolic defect in metachromatic leukodystrophy (MLD).
Trans Am Neurol Assoc
1967
0.75
104
Degenerative disease of the central nervous system.
Adv Pediatr
1969
0.75
105
Persistent feeding arteries to angiographically completely embolized arteriovenous malformation demonstrated by intraoperative color-flow Doppler testing: report of two cases.
Surg Neurol
1995
0.75
106
Sulphatide synthesis in isolated oligodendroglial and neuronal cells.
J Neurochem
1974
0.75
107
Cerebrospinal fluid myelin basic protein and multiple sclerosis.
Adv Exp Med Biol
1978
0.75
108
Amyotrophic lateral sclerosis: summary of a conference.
Science
1973
0.75
109
Plasmapheresis and the Guillain-Barré syndrome.
Ann Neurol
1987
0.75
110
Therapeutic trials for multiple sclerosis.
Ann Neurol
1990
0.75
111
Biochemical studies of myelination: the synthesis of sulfatides and the role of sulfatide-containing lipoproteins.
Trans Am Neurol Assoc
1968
0.75
112
Amyotrophic lateral sclerosis.
Johns Hopkins Med J
1975
0.75
113
A biochemical parameter of myelination in myelinating tissue culture.
Trans Am Neurol Assoc
1969
0.75
114
Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.
Trans Am Neurol Assoc
1976
0.75